BDNF and Alzheimer disease: Our results support the use of AAV-based gene therapy for AD through the local delivery of BDNF to the hippocampus, which has the highest level of BDNF mRNA in the CNS and is also assumed to have a critical role in the early clinical manifestations of AD.89